Allergy Therapeutics PLC Stock
€0.13
Your prediction
Allergy Therapeutics PLC Stock
Pros and Cons of Allergy Therapeutics PLC in the next few years
Pros
Cons
Performance of Allergy Therapeutics PLC vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Allergy Therapeutics PLC | 0.790% | 9.402% | 12.281% | 66.234% | 9.402% | 169.474% | -21.231% |
| Beximco Pharmaceuticals Ltd. GDR | 0.000% | 7.143% | 5.727% | 10.092% | 7.143% | -6.796% | -56.757% |
| Eledon Pharmaceuticals Inc. | 1.480% | 7.031% | 3.008% | -68.578% | 7.031% | -46.899% | -88.291% |
| SELLAS Life Sciences Group Inc | -0.430% | 22.222% | 131.000% | 243.069% | 22.222% | 36.579% | -36.469% |
News
Datavault AI and The Dream Bowl to Set New Benchmark in Sports Innovation with World’s First Tokenized Autograph Session, Featuring Current and Future NFL Stars - Live on ESPN+
30 former NFL star players from different NFL Teams will autograph on-site up to 3,000 The Dream Bowl memorabilia items such as helmets, footballs, jerseys, and live-autographs by Notable
Can ASTS Stock Beat the Market in 2026?
AST SpaceMobile (NASDAQ: ASTS) was a bad investment from 2020 to the start of 2024. The stock woefully underperformed the S&P 500 during that stretch and went from $20 per share to $2 per share
3 Absurdly Cheap Dividend Stocks to Buy for Less Than $100
Buying dividend stocks at low prices can have two positive benefits. The first is that if you're buying low, the yield can be higher than normal. It can provide you with some high dividend income


